Session Slides

Masters of Pediatric Dermatology

2021 MOPD
Psoriasis: What’s New

Adelaide A. Hebert, MD

South Beach Symposium

2021 SBS Part I
Biologics in Dermatology

David E. Cohen, MD, MPH

2021 SBS Part I
The Logic Behind Biologics for Psoriasis

Mark Lebwohl, MD

2021 SBS Part I
Pharmaceutical Breakthroughs

Leon H. Kircik, MD

2021 PsA Satellite Symposium

2021 PsA Satellite Symposium
Comorbidities in PsA

Alexis Ogdie, MD MSCE

2021 PsA Satellite Symposium
Psoriatic Disease Treatment by Domain of Disease

Joseph F. Merola, MD, MMSc

2021 PsA Satellite Symposium
Time to Think About Both Skin and Joint Disease

Alice B. Gottlieb MD, PhD

Scientific Guidelines
Faculty Interview Podcasts
Apr 5, 2021:

Adelaide Hebert,
MD

Clinical Pearls About Treatment of Psoriasis

Adelaide Hebert, MD, shares some highlights and clinical pearls about treatment of psoriasis in pediatric patients, including:

  • What is your personal approach to treating psoriasis in pediatric patients compared to other age groups?
  • Can you highlight the different class of therapeutics currently indicated to treat pediatric patients with psoriasis?
  • Are there any considerations to be made when prescribing treatment for psoriasis in patients across the age spectrum, from infants to adolescents?
  • How do you educate patients and families to deal with the psychological aspects of psoriasis, as well as with treatment adherence?

Podcast also available on:

Apr 5, 2021:

Mark Lebwohl,
MD

New and Emerging Therapies for Treatment of Psoriasis

Mark Lebwohl, MD, discusses the new and emerging therapies for treatment of psoriasis, including:

  • Can you elaborate on the different classes of biologics currently indicated for treatment of psoriasis?
  • What are some of the most promising therapies that will likely be part of the psoriasis treatment table in the near future?
  • Do you foresee that they will be also approved for pediatric psoriasis patients, or only for the adult population?
  • Where do you feel biologics fit in with the other approved treatments for psoriasis, or overall in the treatment regimen?
  • Can you tell us what you feel is still needed in terms of developing new treatments for psoriasis?

Podcast also available on:

Apr 5, 2021:

Alice Gottlieb,
MD

Time to Think About Both Skin and Joint Disease

Alice Gottlieb, MD, Chair of the CME symposium “Time to Think About Both Skin and Joint Disease: Optimizing the Diagnosis and Management of Psoriatic Arthritis” at SBS 2021, shares some clinical pearls about the dermatologist’s role in screening and diagnosing psoriatic arthritis, including:

  • Can you tell us about screening tools that are currently available for psoriatic arthritis patients?
  • What is your personal approach to diagnosing psoriatic arthritis patients?
  • What do you feel the dermatologist’s role is in treatment of psoriatic arthritis? Do you have any advice for dermatologists working with rheumatologists as a team approach?

Podcast also available on:

Apr 5, 2021:

Glenn Speer,
PhD

Patient Interview

Glenn Speer, PhD, has been working with dermatologists to manage his psoriatic arthritis symptoms for over 20 years. In this video interview, Glenn tells his story, including:

  • Can you share with us your experience of your path to diagnosis?
  • Can you tell us about what type of treatments you tried and how long and how long it took you to identify the best treatment?
  • Can you share more with us about how PsA has affected both your personal and professional life?
  • Do you have a message that you’d like to convey to those watching this interview, regarding how they can motivate their patients if a treatment doesn’t work and encourage them to try the different recommended treatments, as well as adhere to those treatment?

Podcast also available on:

Patient Resources

Psoriatic Arthritis Patient Resources

Psoriasis Patient Resources